Nonradioactive surgical guidance with radiofrequency identification technology for locating nonpalpable breast lesions; Initial experiences of the RFID Localizer I Trial

2020 ◽  
Vol 138 ◽  
pp. S117
Author(s):  
A. Christenhusz ◽  
B. Den Dekker ◽  
T. Van Dalen ◽  
L. Jongen ◽  
M. Van der Schaaf ◽  
...  
2016 ◽  
Vol 23 (6) ◽  
pp. 1824-1830 ◽  
Author(s):  
Charles E. Cox ◽  
Norbert Garcia-Henriquez ◽  
M. Jordan Glancy ◽  
Pat Whitworth ◽  
John M. Cox ◽  
...  

2016 ◽  
Vol 207 (4) ◽  
pp. W69-W72 ◽  
Author(s):  
Victoria Mango ◽  
Richard Ha ◽  
Ameer Gomberawalla ◽  
Ralph Wynn ◽  
Sheldon Feldman

2016 ◽  
Vol 9 (2) ◽  
pp. 143-149 ◽  
Author(s):  
Linnea Langhans ◽  
Thomas Levin Klausen ◽  
Tove Filtenborg Tvedskov ◽  
Maj-Lis Talman ◽  
Peter Sandor Oturai ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 2923
Author(s):  
Tomoko Kurita ◽  
Kanae Taruno ◽  
Seigo Nakamura ◽  
Hiroyuki Takei ◽  
Katsutoshi Enokido ◽  
...  

Accurate pre-operative localization of nonpalpable lesions plays a pivotal role in guiding breast-conserving surgery (BCS). In this multicenter feasibility study, nonpalpable breast lesions were localized using a handheld magnetic probe (TAKUMI) and a magnetic marker (Guiding-Marker System®). The magnetic marker was preoperatively placed within the target lesion under ultrasound or stereo-guidance. Additionally, a dye was injected subcutaneously to indicate the extent of the tumor excision. Surgeons checked for the marker within the lesion using a magnetic probe. The magnetic probe could detect the guiding marker and accurately localize the target lesion intraoperatively. All patients with breast cancer underwent wide excision with a safety margin of ≥5 mm. The presence of the guiding-marker within the resected specimen was the primary outcome and the pathological margin status and re-excision rate were the secondary outcomes. Eighty-seven patients with nonpalpable lesions who underwent BCS, from January to March of 2019 and from January to July of 2020, were recruited. The magnetic marker was detected in all resected specimens. The surgical margin was positive only in 5/82 (6.1%) patients; these patients underwent re-excision. This feasibility study demonstrated that the magnetic guiding localization system is useful for the detection and excision of nonpalpable breast lesions.


1996 ◽  
Vol 3 (2) ◽  
pp. 115-120 ◽  
Author(s):  
Robert M. Spillane ◽  
Gary J. Whitman ◽  
Kathleen A. McCarthy ◽  
Carol A. Hulka ◽  
Deborah A. Hall ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document